Last $4.16 USD
Change Today +0.08 / 1.96%
Volume 110.8K
THLD On Other Exchanges
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tillman E. Pearce M.D.

Chief Medical Officer, Threshold Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2013


Dr. Tillman E. Pearce, M.D., has been the Chief Medical Officer at Threshold Pharmaceuticals Inc since February 17, 2012. Dr. Pearce oversees the development of Threshold's TH-302, a clinical stage hypoxia-targeted cancer therapeutic being evaluated in a variety of cancers, including a Phase 3 trial in patients with soft tissue sarcoma and a Phase 2b trial in patients with pancreatic cancer. Dr. Pearce has almost two decades of international experience in drug development, ...

Read Full Background

Corporate Headquarters*

170 Harbor Way
South San Francisco, California 94080

United States

Phone: 650-474-8200
Fax: 650-474-2529

Board Members Memberships*

There is no Board Members Memberships data available.


Medical College Of Georgia

Other Affiliations*

Annual Compensation*

Total Annual Compensation$361,000

Stock Options*

All Other Compensation$1,344
Exercised Options20,000
Exercised Options Value$39,600
Exercisable Options120,833
Exercisable Options Value$114,445
Unexercisable Options249,167
Unexercisable Options Value$163,855
Total Value of Options$317,900
Total Number of Options390,000

Total Compensation*

Total Annual Cash Compensation$483,956
Total Short Term Compensation$361,000
Other Long Term Compensation$1,344
Total Calculated Compensation$1,048,366
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THLD:US $4.16 USD +0.08


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THRESHOLD PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at